Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wort

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Thorax|December 17, 2018
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertensionBenjamin E Garfield, Alexi Crosby, Dongmin Shao, et al.
International Journal of Cardiology|November 26, 2020
Right ventricular dysfunction in critically ill COVID-19 ARDSCaroline Bleakley, Suveer Singh, Benjamin Garfield, et al.
ERJ Open Research|May 12, 2018
A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung diseaseSimon Bax, Charlene Bredy, Aleksander Kempny, et al.
Chest|July 28, 2019
Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung DiseaseSimon Bax, Joseph Jacob, Riaz Ahmed, et al.
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
European Heart Journal Open|January 15, 2026
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profilingChinthaka B Samaranayake, Yen-Cheng Chen, Min Fang, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
ERJ Open Research|December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtypeIfan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 3, 2024
Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertensionLaura C Price, Vaileios Kouranos, Robert Baughman, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertensionKatherine Bunclark, Michael Newnham, Yi-Da Chiu, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Thorax|December 17, 2018
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertensionBenjamin E Garfield, Alexi Crosby, Dongmin Shao, et al.
International Journal of Cardiology|November 26, 2020
Right ventricular dysfunction in critically ill COVID-19 ARDSCaroline Bleakley, Suveer Singh, Benjamin Garfield, et al.
ERJ Open Research|May 12, 2018
A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung diseaseSimon Bax, Charlene Bredy, Aleksander Kempny, et al.
Chest|July 28, 2019
Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung DiseaseSimon Bax, Joseph Jacob, Riaz Ahmed, et al.
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
European Heart Journal Open|January 15, 2026
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profilingChinthaka B Samaranayake, Yen-Cheng Chen, Min Fang, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
ERJ Open Research|December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtypeIfan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 3, 2024
Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertensionLaura C Price, Vaileios Kouranos, Robert Baughman, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2019
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertensionKatherine Bunclark, Michael Newnham, Yi-Da Chiu, et al.
Pageof 9